Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPTACOPAN vs IRINOTECAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IPTACOPAN vs IRINOTECAN: Safety Overview

Metric IPTACOPAN IRINOTECAN
Total FAERS Reports 468 27,965
Deaths Reported 23 4,530
Death Rate 4.9% 16.2%
Hospitalizations 88 10,384
Average Patient Age 48.8 yrs 58.7 yrs
% Female Patients 53.4% 41.4%
FDA Approval Date Dec 5, 2023 Apr 11, 2022
Manufacturer Novartis Pharmaceuticals Corporation Armas Pharmaceuticals Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription